scispace - formally typeset
M

Mikolaj Ogrodnik

Researcher at Mayo Clinic

Publications -  35
Citations -  6158

Mikolaj Ogrodnik is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Senescence & Senolytic. The author has an hindex of 20, co-authored 28 publications receiving 3685 citations. Previous affiliations of Mikolaj Ogrodnik include Nencki Institute of Experimental Biology & Hebrew University of Jerusalem.

Papers
More filters
Journal ArticleDOI

Targeting cellular senescence prevents age-related bone loss in mice

TL;DR: A causal role for senescent cells in bone loss with aging is established, and targeting these cells has both anti-resorptive and anabolic effects on bone, which suggests a novel treatment strategy not only for osteoporosis, but also for multiple age-related comorbidities.
Journal ArticleDOI

Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice

TL;DR: This is the first study to demonstrate that chronic clearance of senescent cells improves established vascular phenotypes associated with aging and chronic hypercholesterolemia, and may be a viable therapeutic intervention to reduce morbidity and mortality from cardiovascular diseases.
Journal ArticleDOI

JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age

TL;DR: It is found that senescent fat progenitor cells accumulate in adipose tissue with aging and acquire a senescence-associated secretory phenotype (SASP), with increased production of proinflammatory cytokines compared with nonsenescent cells.